By Ed Susman, Contributing Writer, MedPage Today
Published: May 02, 2010
Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston.
VANCOUVER -- Treatment of patients with bilateral retinoblastoma with human growth hormone exposes the individual to a risk of a second tumor similar to that seen in patients with other primary cancers who receive growth hormone, researchers suggested here.
Data shows one-in-six affected overall; higher rates among minority and underprivileged
ST. LOUIS, March 30 /PRNewswire/ -- A new report released by the American Optometric Association (AOA) identifies surprising new insights into the vision and eye health of infants across the U.S. The findings from last year's InfantSEE® Weeks pilot program, a year-long, federally-funded public health initiative, revealed a higher-than-expected number of infants with undiagnosed and untreated vision...
e! Science News
Source: Sbarro Health Research Organization
Published: Tuesday, January 26, 2010 - 17:25 in Health & Medicine
January 26, 2010 -- (PHILADELPHIA, PA) Retinoblastoma is a pediatric eye cancer initiated by the loss or mutation of both copies of the retinoblastoma gene. Current evidence suggests that additional genetic alterations are required for retinoblastoma to become fully malignant. Researchers working at the Sbarro Institute for Cancer Research...
SHANGHAI, Oct. 14 (UPI) -- Chinese ophthalmologists say they've found non-invasive bioluminescence imaging can reveal eye tumors sooner and without having to resort to biopsy.
Currently physicians rely on biopsy analysis to determine the progression of eye cancer. But the new study suggests bioluminescence imaging of the eye will allow earlier detection of cancerous tumors, thereby allowing doctors to quickly choose a treatment...
On approaching the flying eye hospital, it looks like any of the other passenger jets on the runway waiting to take holidaymakers to exotic destinations.
But this DC-10 jet is exceptional - it houses the only airborne operating theatre for eye treatment in the world.
Its mission is to tackle avoidable sight loss and its charter reaches developing countries where 90% of the world's 45 million blind people...
Blog Categories
Uncategorized
(5)
